Semaglutide (Rybelsus®) receives FDA approval as first line treatment for Type 2 Diabetes Mellitus

Novo Nordisk

Semaglutide, available in oral and subcutaneous dosage forms, is a selective glucagon-like peptide-1 receptor agonist with 3 main mechanisms of action . . .

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

cardiovascular jumping jacks

Rev Up Your Heart: At-home Cardio Workouts to Energise

In today’s fast-paced world, finding time to hit the gym can be a challenge, especially in bustling Asian cities. However, cardiovascular health is crucial for overall well-being, and regular exercise can significantly reduce the risk of heart disease.  With that in mind, let’s explore some easy-to-follow, at-home exercises that can help boost your cardio fitness without stepping out of your living room.

Read More »
Stafne Bone Cyst

Stafne Bone Cysts: What You Need to Know About This Benign Jaw Lesion

Stafne bone cysts are a relatively common and benign jaw lesion that can occur in some individuals. These cysts are typically discovered incidentally during routine dental X-rays and are rarely symptomatic. However, they can cause significant aesthetic concerns or interfere with dental prosthetics in some cases. In this article, we will explore Stafne bone cysts in more detail, including their causes, symptoms, diagnosis, and treatment options.

Read More »

People also read: